Short Interest in Apyx Medical Co. (NASDAQ:APYX) Declines By 47.5%

Apyx Medical Co. (NASDAQ:APYX) saw a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 371,100 shares, a drop of 47.5% from the March 31st total of 706,700 shares. Approximately 1.3% of the shares of the company are sold short. Based on an average daily trading volume, of 154,700 shares, the days-to-cover ratio is presently 2.4 days.

Apyx Medical Stock Down 2.0 %

NASDAQ APYX traded down $0.03 during trading hours on Friday, hitting $1.45. 58,368 shares of the company’s stock traded hands, compared to its average volume of 85,303. The company has a debt-to-equity ratio of 1.23, a quick ratio of 4.74 and a current ratio of 5.52. Apyx Medical has a 52 week low of $1.21 and a 52 week high of $7.97. The business’s fifty day moving average price is $1.67 and its two-hundred day moving average price is $2.13.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings data on Thursday, March 21st. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.06). The company had revenue of $14.66 million during the quarter, compared to analysts’ expectations of $14.40 million. Apyx Medical had a negative return on equity of 54.90% and a negative net margin of 35.75%. On average, research analysts expect that Apyx Medical will post -0.74 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Apyx Medical

Several large investors have recently made changes to their positions in the business. AIGH Capital Management LLC grew its holdings in Apyx Medical by 7.7% during the 4th quarter. AIGH Capital Management LLC now owns 2,040,540 shares of the company’s stock valued at $5,346,000 after buying an additional 145,309 shares in the last quarter. Taylor Frigon Capital Management LLC increased its holdings in shares of Apyx Medical by 2.9% in the 4th quarter. Taylor Frigon Capital Management LLC now owns 638,965 shares of the company’s stock worth $1,674,000 after buying an additional 17,818 shares during the last quarter. Silverberg Bernstein Capital Management LLC raised its position in shares of Apyx Medical by 1.2% during the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock valued at $845,000 after buying an additional 7,507 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in shares of Apyx Medical by 44.5% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 608,628 shares of the company’s stock valued at $1,595,000 after acquiring an additional 187,350 shares during the last quarter. Finally, Worth Venture Partners LLC grew its position in Apyx Medical by 12.0% in the fourth quarter. Worth Venture Partners LLC now owns 518,198 shares of the company’s stock worth $1,358,000 after acquiring an additional 55,592 shares in the last quarter. 55.33% of the stock is currently owned by hedge funds and other institutional investors.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.